{"SPADE_UN_15849": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15849", "Peptide Name": "B1CTcu5-LIAG", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LAANFLPQILCKIARKC", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/E3SYG2##D2K8D1##C3RTH8"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A431 (50% Cytotoxicity>100 µg/ml)", "Hemolytic Activity": "Human erythrocytes:30% Hemolysis=200 µM", "Cytotoxicity": "HEK293:50%Cytotoxicity>100 µg/ml; PBMC:50%Cytotoxicity>100 µg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C86H148N24O20S2", "Mass": 1902.37, "PI": 9.5, "Net Charge": 3, "Hydrophobicity": 0.75, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides", "Pubmed ID": "25997127", "Reference": "PLoS One. 2015 May 21;10(5)e0124210.", "Author": "Abraham P, Sundaram A, R A, V R, George S, Kumar KS.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25997127"}], "Frequent Amino Acids": "ALC", "Absent Amino Acids": "DEGHMOSTUVWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 10, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_01700", "Similarity": 1.0, "Sequence": "FFPLIAGLAANFLPQILCKIARKC"}, {"SPADE_ID": "SPADE_N_15875", "Similarity": 1.0, "Sequence": "LIAGLAANFLPQILCKIARKC"}, {"SPADE_ID": "SPADE_UN_12434", "Similarity": 1.0, "Sequence": "LIAGLAANFLPQILCKIARKC"}]}}}